The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)
Open accessAbstract
Myocardial diseases are associated with an increased risk of potentially fatal cardiac arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compaction, arrhythmogenic cardiomyopathy, and myo-pericarditis. Practicing cardiologists and sport physicians are required to identify high-risk individuals harbouring these cardiac diseases in a timely fashion in the setting of preparticipation screening or medical consultation and provide appropriate advice regarding the participation in competitive sport activities and/or regular exercise programmes. Many asymptomatic (or mildly symptomatic) patients with cardiomyopathies aspire to participate in leisure-time and amateur sport activities to take advantage of the multiple benefits of a physically active lifestyle. In 2005, The European Society of Cardiology (ESC) published recommendations for participation in competitive sport in athletes with cardiomyopathies and myo-pericarditis. One decade on, these recommendations are partly obsolete given the evolving knowledge of the diagnosis, management and treatment of cardiomyopathies and myo-pericarditis. The present document, therefore, aims to offer a comprehensive overview of the most updated recommendations for practicing cardiologists and sport physicians managing athletes with cardiomyopathies and myo-pericarditis and provides pragmatic advice for safe participation in competitive sport at professional and amateur level, as well as in a variety of recreational physical activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Pelliccia, A. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi325 · Cited by 983
Self-citationExercise-induced right ventricular dysfunction and structural remodelling in endurance athletes
La Gerche, A., Burns, A. T., Mooney, D. J., Inder, W. J., Taylor, A. J., Bogaert, J., MacIsaac, A. I., Heidbüchel, H., & Prior, D. L. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr397 · Cited by 776
Self-citationMaron, B. J., Chaitman, B. R., Ackerman, M. J., Bayés de Luna, A., Corrado, D., Crosson, J. E., Deal, B. J., Driscoll, D. J., Estes, N. A. M., Araújo, C. G. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128363.85581.e1 · Cited by 591
Self-citationEtiology of Sudden Death in Sports
Finocchiaro, G., Papadakis, M., Robertus, J.-L., Dhutia, H., Steriotis, A. K., Tome, M., Mellor, G., Merghani, A., Malhotra, A., Behr, E., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.062 · Cited by 555
Self-citationCardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training
Benito, B., Gay-Jordi, G., Serrano-Mollar, A., Guasch, E., Shi, Y., Tardif, J.-C., Brugada, J., Nattel, S., & Mont, L. (2011) · Circulation · doi:10.1161/circulationaha.110.938282 · Cited by 478
Heidbüchel, H. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00282-3 · Cited by 395
Self-citationLampert, R., Olshansky, B., Heidbuchel, H., Lawless, C., Saarel, E., Ackerman, M., Calkins, H., Estes, N. A. M., Link, M. S., Maron, B. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000447 · Cited by 286
Research works printed but not linked: 114
- Corrado, 2005, Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology, Eur Heart J, 26, 516, 10.1093/eurheartj/ehi108 · DOI · Paper page
- Maron, 2007, Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association council on nutrition, physical activity and metabolism. Endorsed by the American College of Cardiology Foundation, Circulation, 115, 1643, 10.1161/CIRCULATIONAHA.107.181423 · DOI · Paper page
- Maron, 2015, Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 2: preparticipation screening for cardiovascular disease in competitive athletes, J Am Coll Cardiol, 66, 2356, 10.1016/j.jacc.2015.09.034 · DOI
- Pelliccia, 2008, Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities, J Am Coll Cardiol, 52, 1990, 10.1016/j.jacc.2008.08.055 · DOI · Paper page
- Pelliccia, 2018, European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete's heart, Eur Heart J, 39, 1949, 10.1093/eurheartj/ehx532 · DOI · Paper page
- Gersh, 2011, 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 124, e783
- Maron, 2009, Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006, Circulation, 119, 1085, 10.1161/CIRCULATIONAHA.108.804617 · DOI · Paper page
- Harmon, 2015, Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association athletes: a decade in review, Circulation, 132, 10, 10.1161/CIRCULATIONAHA.115.015431 · DOI · Paper page
- Papadakis, 2011, The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin, Eur Heart J, 32, 2304, 10.1093/eurheartj/ehr140 · DOI · Paper page
- Sheikh, 2015, Clinical profile of athletes with hypertrophic cardiomyopathy, Circ Cardiovasc Imaging, 8, e003454, 10.1161/CIRCIMAGING.114.003454 · DOI · Paper page
- Calore, 2015, Clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart, J Electrocardiol, 48, 373, 10.1016/j.jelectrocard.2014.12.016 · DOI
- Sheikh, 2018, Diagnostic yield of genetic testing in young athletes with T-wave inversion, Circulation, 138, 1184, 10.1161/CIRCULATIONAHA.118.034208 · DOI
- Pelliccia, 2008, Outcomes in athletes with marked ECG repolarization abnormalities, N Engl J Med, 358, 152, 10.1056/NEJMoa060781 · DOI · Paper page
- Pelliccia, 1991, The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes, N Engl J Med, 324, 295, 10.1056/NEJM199101313240504 · DOI · Paper page
- Basavarajaiah, 2008, Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy, J Am Coll Cardiol, 51, 2256, 10.1016/j.jacc.2007.12.061 · DOI · Paper page
- Caselli, 2014, Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy, Am J Cardiol, 114, 1383, 10.1016/j.amjcard.2014.07.070 · DOI · Paper page
- Basavarajaiah, 2008, Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening, J Am Coll Cardiol, 51, 1033, 10.1016/j.jacc.2007.10.055 · DOI · Paper page
- Rawlins, 2010, Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes, Circulation, 121, 1078, 10.1161/CIRCULATIONAHA.109.917211 · DOI · Paper page
- Sheikh, 2013, Cardiac adaptation to exercise in adolescent athletes of African ethnicity: an emergent elite athletic population, Br J Sports Med, 47, 585, 10.1136/bjsports-2012-091874 · DOI
- Di Paolo, 2012, The athlete's heart in adolescent Africans: an electrocardiographic and echocardiographic study, J Am Coll Cardiol, 59, 1029, 10.1016/j.jacc.2011.12.008 · DOI
- Pelliccia, 1996, Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes, JAMA, 276, 211, 10.1001/jama.1996.03540030045030 · DOI · Paper page
- Finocchiaro, 2018, Role of Doppler diastolic parameters in differentiating physiological left ventricular hypertrophy from hypertrophic cardiomyopathy, J Am Soc Echocardiogr, 31, 606, 10.1016/j.echo.2017.11.022 · DOI
- Rickers, 2005, Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy, Circulation, 112, 855, 10.1161/CIRCULATIONAHA.104.507723 · DOI · Paper page
- Maron, 2008, Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy, Circ Heart Fail, 1, 184, 10.1161/CIRCHEARTFAILURE.108.768119 · DOI · Paper page
- Sharma, 2000, Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes, J Am Coll Cardiol, 36, 864, 10.1016/S0735-1097(00)00816-0 · DOI · Paper page
- Maron, 1993, Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes, Br Heart J, 69, 125, 10.1136/hrt.69.2.125 · DOI · Paper page
- Maron, 2015, Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology, Circulation, 132, e273
- Harmon, 2014, Incidence of sudden cardiac death in athletes: a state-of-the-art review, Br J Sports Med, 48, 1185, 10.1136/bjsports-2014-093872 · DOI · Paper page
- Malhotra, 2018, Outcomes of cardiac screening in adolescent soccer players, N Engl J Med, 379, 524, 10.1056/NEJMoa1714719 · DOI · Paper page
- Alpert, 2015, Sports and exercise in athletes with hypertrophic cardiomyopathy, Clin Sports Med, 34, 489, 10.1016/j.csm.2015.03.005 · DOI
- Maron, 1994, Surviving competitive athletics with hypertrophic cardiomyopathy, Am J Cardiol, 73, 1098, 10.1016/0002-9149(94)90290-9 · doi:10.1016/0002-9149(94)90290-9
- Pelliccia, 2018, Does sport participation worsen the clinical course of hypertrophic cardiomyopathy? Clinical outcome of hypertrophic cardiomyopathy in athletes, Circulation, 137, 531, 10.1161/CIRCULATIONAHA.117.031725 · DOI
- Spirito, 2014, Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors, Am J Cardiol, 113, 1550, 10.1016/j.amjcard.2014.01.435 · DOI
- Ho, 2010, Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy, N Engl J Med, 363, 552, 10.1056/NEJMoa1002659 · DOI · Paper page
- Ho, 2013, T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy, Circ Cardiovasc Imaging, 6, 415, 10.1161/CIRCIMAGING.112.000333 · DOI · Paper page
- Ho, 2002, Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy, Circulation, 105, 2992, 10.1161/01.CIR.0000019070.70491.6D · DOI · Paper page
- Gray, 2011, Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy, Int J Cardiol, 152, 258, 10.1016/j.ijcard.2011.07.095 · DOI
- Jensen, 2013, Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing, Circulation, 127, 48, 10.1161/CIRCULATIONAHA.111.090514 · DOI
- Vermeer, 2017, Penetrance of hypertrophic cardiomyopathy in children who are mutation positive, J Pediatr, 188, 91, 10.1016/j.jpeds.2017.03.033 · DOI
- Caselli, 2018, The electrocardiogram and the phenotypic expression of hypertrophic cardiomyopathy, Eur Heart J
- Pinto, 2016, Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases, Eur Heart J, 37, 1850, 10.1093/eurheartj/ehv727 · DOI · Paper page
- Rapezzi, 2013, Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 34, 1448, 10.1093/eurheartj/ehs397 · DOI · Paper page
- Gavazzi, 1993, The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. SPIC (Italian Multicenter Cardiomyopathy Study) Group, Am Heart J, 125, 410, 10.1016/0002-8703(93)90020-A · DOI
- Pelliccia, 1999, Physiologic left ventricular cavity dilatation in elite athletes, Ann Intern Med, 130, 23, 10.7326/0003-4819-130-1-199901050-00005 · DOI · Paper page
- Finocchiaro, 2017, Effect of sex and sporting discipline on LV adaptation to exercise, JACC Cardiovasc Imaging, 10, 965, 10.1016/j.jcmg.2016.08.011 · DOI · Paper page
- Abergel, 2004, Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up, J Am Coll Cardiol, 44, 144, 10.1016/j.jacc.2004.02.057 · DOI · Paper page
- Millar, 2016, Exercise echocardiography has a high sensitivity and specificity in differentiating athlete’s heart from dilated cardiomyopathy, Circulation, 134, A15662
- Claessen, 2018, Exercise cardiac magnetic resonance to differentiate athlete's heart from structural heart disease, Eur Heart J Cardiovasc Imaging, 19, 1062, 10.1093/ehjci/jey050 · DOI
- Gulati, 2013, Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy, JAMA, 309, 896, 10.1001/jama.2013.1363 · DOI · Paper page
- Halliday, 2017, Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction, Circulation, 135, 2106, 10.1161/CIRCULATIONAHA.116.026910 · DOI · Paper page
- Spezzacatene, 2015, . Arrhythmogenic phenotype in dilated cardiomyopathy: natural history and predictors of life-threatening arrhythmias, J Am Heart Assoc, 4, e002149, 10.1161/JAHA.115.002149 · DOI
- van Rijsingen, 2012, Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study, J Am Coll Cardiol, 59, 493, 10.1016/j.jacc.2011.08.078 · DOI · Paper page
- Webb-Peploe, 2000, Different response of patients with idiopathic and ischaemic dilated cardiomyopathy to exercise training, Int J Cardiol, 74, 215, 10.1016/S0167-5273(00)00293-X · DOI
- Haykowsky, 2013, Meta-analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions, Am J Cardiol, 111, 1466, 10.1016/j.amjcard.2013.01.303 · DOI · Paper page
- Hershberger, 2013, Dilated cardiomyopathy: the complexity of a diverse genetic architecture, Nat Rev Cardiol, 10, 531, 10.1038/nrcardio.2013.105 · DOI · Paper page
- Towbin, 2015, Left ventricular non-compaction cardiomyopathy, Lancet, 386, 813, 10.1016/S0140-6736(14)61282-4 · DOI · Paper page
- Steffel, 2009, Electrocardiographic characteristics at initial diagnosis in patients with isolated left ventricular noncompaction, Am J Cardiol, 104, 984, 10.1016/j.amjcard.2009.05.042 · DOI
- Jenni, 2001, Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy, Heart, 86, 666, 10.1136/heart.86.6.666 · DOI · Paper page
- Chin, 1990, Isolated noncompaction of left ventricular myocardium. A study of eight cases, Circulation, 82, 507, 10.1161/01.CIR.82.2.507 · DOI · Paper page
- Gebhard, 2012, Reduced left ventricular compacta thickness: a novel echocardiographic criterion for non-compaction cardiomyopathy, J Am Soc Echocardiogr, 25, 1050, 10.1016/j.echo.2012.07.003 · doi:10.1016/j.echo.2012.07.003
- Gati, 2013, Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?, Heart, 99, 401, 10.1136/heartjnl-2012-303418 · DOI · Paper page
- Gati, 2014, Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations, Circulation, 130, 475, 10.1161/CIRCULATIONAHA.114.008554 · DOI · Paper page
- Caselli, 2015, Left ventricular noncompaction diagnosis and management relevant to pre-participation screening of athletes, Am J Cardiol, 116, 801, 10.1016/j.amjcard.2015.05.055 · DOI
- Caselli, 2016, Prominent left ventricular trabeculations in competitive athletes: a proposal for risk stratification and management, Int J Cardiol, 223, 590, 10.1016/j.ijcard.2016.08.272 · DOI
- Petersen, 2005, Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging, J Am Coll Cardiol, 46, 101, 10.1016/j.jacc.2005.03.045 · DOI · Paper page
- Zemrak, 2014, The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study, J Am Coll Cardiol, 64, 1971, 10.1016/j.jacc.2014.08.035 · DOI · Paper page
- Corrado, 2017, Arrhythmogenic right ventricular cardiomyopathy, N Engl J Med, 376, 61, 10.1056/NEJMra1509267 · DOI · Paper page
- Thiene, 1988, Right ventricular cardiomyopathy and sudden death in young people, N Engl J Med, 318, 129, 10.1056/NEJM198801213180301 · DOI · Paper page
- Bagnall, 2016, A prospective study of sudden cardiac death among children and young adults, N Engl J Med, 374, 2441, 10.1056/NEJMoa1510687 · DOI · Paper page
- Marcus, 2010, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria, Circulation, 121, 1533, 10.1161/CIRCULATIONAHA.108.840827 · DOI · Paper page
- Nasir, 2004, Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria, Circulation, 110, 1527, 10.1161/01.CIR.0000142293.60725.18 · DOI · Paper page
- Bauce, 2010, Differences and similarities between arrhythmogenic right ventricular cardiomyopathy and athlete's heart adaptations, Br J Sports Med, 44, 148, 10.1136/bjsm.2007.042853 · DOI
- Perazzolo Marra, 2015, Arrhythmogenic right ventricular cardiomyopathy. Contribution of cardiac magnetic resonance imaging to the diagnosis, Herz, 40, 600, 10.1007/s00059-015-4228-0 · DOI
- Zaidi, 2013, Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin, Circulation, 127, 1783, 10.1161/CIRCULATIONAHA.112.000270 · DOI
- D'Ascenzi, 2017, RV remodeling in olympic athletes, JACC Cardiovasc Imaging, 10, 385, 10.1016/j.jcmg.2016.03.017 · DOI
- Quarta, 2011, Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised Task Force Criteria, Circulation, 123, 2701, 10.1161/CIRCULATIONAHA.110.976936 · DOI · Paper page
- Kapplinger, 2011, Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise, J Am Coll Cardiol, 57, 2317, 10.1016/j.jacc.2010.12.036 · DOI · Paper page
- Calkins, 2017, Risk stratification in arrhythmogenic right ventricular cardiomyopathy, Circulation, 136, 2068, 10.1161/CIRCULATIONAHA.117.030792 · DOI · Paper page
- Maupain, 2018, Risk stratification in arrhythmogenic right ventricular cardiomyopathy/dysplasia without an implantable cardioverter-defibrillator, JACC Clin Electrophysiol, 4, 757, 10.1016/j.jacep.2018.04.017 · DOI
- Kirchhof, 2006, Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice, Circulation, 114, 1799, 10.1161/CIRCULATIONAHA.106.624502 · DOI · Paper page
- James, 2013, Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers, J Am Coll Cardiol, 62, 1290, 10.1016/j.jacc.2013.06.033 · DOI · Paper page
- Saberniak, 2014, Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members, Eur J Heart Fail, 16, 1337, 10.1002/ejhf.181 · DOI · Paper page
- Ruwald, 2015, Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy, Eur Heart J, 36, 1735, 10.1093/eurheartj/ehv110 · DOI · Paper page
- Sawant, 2014, Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations, J Am Heart Assoc, 3, e001471, 10.1161/JAHA.114.001471 · DOI · Paper page
- La Gerche, 2010, Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin, Heart, 96, 1268, 10.1136/hrt.2009.189621 · DOI · Paper page
- Schnell, 2015, Recognition and significance of pathological T-wave inversions in athletes, Circulation, 131, 165, 10.1161/CIRCULATIONAHA.114.011038 · DOI
- Sharma, 2017, International recommendations for electrocardiographic interpretation in athletes, J Am Coll Cardiol, 69, 1057, 10.1016/j.jacc.2017.01.015 · DOI · Paper page
- Lampert, 2017, Safety of sports for athletes with implantable cardioverter-defibrillators: long-term results of a prospective multinational registry, Circulation, 135, 2310, 10.1161/CIRCULATIONAHA.117.027828 · DOI
- Heidbuchel, 2007, Implantable cardioverter defibrillator therapy in athletes, Cardiol Clin, 25, 467, 10.1016/j.ccl.2007.07.004 · DOI
- Heidbuchel, 2014, Exercise and competitive sports in patients with an implantable cardioverter-defibrillator, Eur Heart J, 35, 3097, 10.1093/eurheartj/ehu130 · DOI
- Heidbuchel, 2006, Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions Part II: ventricular arrhythmias, channelopathies and implantable defibrillators, Eur J Cardiovasc Prev Rehabil, 13, 676, 10.1097/01.hjr.0000239465.26132.29 · DOI · Paper page
- Pelliccia, 2013, Leisure-time physical activity and sport participation in patients with Cardiomyopathies, Card Electrophysiol Clin, 5, 65, 10.1016/j.ccep.2012.11.005 · DOI
- Saberi, 2017, Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial, JAMA, 317, 1349, 10.1001/jama.2017.2503 · DOI · Paper page
- Klempfner, 2015, Efficacy of exercise training in sympomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center, Eur J Prev Cardiol, 22, 13, 10.1177/2047487313501277 · DOI
- Olivotto, 2013, Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy, J Am Coll Cardiol, 62, 449, 10.1016/j.jacc.2013.03.062 · DOI · Paper page
- Sinagra, 2016, Myocarditis in Clinical Practice, Mayo Clin Proc, 91, 1256, 10.1016/j.mayocp.2016.05.013 · DOI · Paper page
- Caforio, 2013, Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 34, 2636, 10.1093/eurheartj/eht210 · DOI · Paper page
- Morgera, 1992, Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes, Am Heart J, 124, 455, 10.1016/0002-8703(92)90613-Z · DOI · Paper page
- Pinamonti, 1988, Echocardiographic findings in myocarditis, Am J Cardiol, 62, 285, 10.1016/0002-9149(88)90226-3 · DOI · Paper page
- Caforio, 2007, A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis, Eur Heart J, 28, 1326, 10.1093/eurheartj/ehm076 · DOI · Paper page
- Friedrich, 2009, Cardiovascular magnetic resonance in myocarditis: a JACC White Paper, J Am Coll Cardiol, 53, 1475, 10.1016/j.jacc.2009.02.007 · DOI · Paper page
- Schnell, 2016, Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie?, Br J Sports Med, 50, 111, 10.1136/bjsports-2014-094546 · DOI
- Mewton, 2015, Myocardial biomarkers and delayed enhanced cardiac magnetic resonance relationship in clinically suspected myocarditis and insight on clinical outcome, J Cardiovasc Med (Hagerstown), 16, 696, 10.2459/JCM.0000000000000024 · DOI
- van de Schoor, 2016, Myocardial fibrosis in athletes, Mayo Clin Proc, 91, 1617, 10.1016/j.mayocp.2016.07.012 · DOI · Paper page
- Schumm, 2014, Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis, J Cardiovasc Magn Reson, 16, 14., 10.1186/1532-429X-16-14 · DOI
- Grün, 2012, Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery, J Am Coll Cardiol, 59, 1604, 10.1016/j.jacc.2012.01.007 · DOI · Paper page
- Cooper, 2008, Usefulness of immunosuppression for giant cell myocarditis, Am J Cardiol, 102, 1535, 10.1016/j.amjcard.2008.07.041 · DOI · Paper page
- Kiel, 1989, Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence, Eur J Epidemiol, 5, 348, 10.1007/BF00144836 · DOI
- Phillips, 1986, Sudden cardiac death in Air Force recruits: a 20-year review, JAMA, 256, 2696, 10.1001/jama.1986.03380190066026 · doi:10.1001/jama.1986.03380190066026 · Paper page
- Bohm, 2016, Data from a nationwide registry on sports-related sudden cardiac deaths in Germany, Eur J Prev Cardiol, 23, 649, 10.1177/2047487315594087 · DOI · Paper page
- Anzini, 2013, Long-term evolution and prognostic stratification of biopsy-proven active myocarditis, Circulation, 128, 2384, 10.1161/CIRCULATIONAHA.113.003092 · DOI · Paper page
- Magnani, 2006, Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors, Am Heart J, 151, 463, 10.1016/j.ahj.2005.03.037 · DOI · Paper page
- Imazio, 2015, Evaluation and treatment of pericarditis: a systematic review, JAMA, 314, 1498, 10.1001/jama.2015.12763 · DOI · Paper page
- Imazio, 2010, Controversial issues in the management of pericardial diseases, Circulation, 121, 916, 10.1161/CIRCULATIONAHA.108.844753 · DOI · Paper page
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Self-citationManagement of post-acute covid-19 in primary care
Greenhalgh, T., Knight, M., A’Court, C., Buxton, M., & Husain, L. (2020) · BMJ · doi:10.1136/bmj.m3026 · Cited by 1,689
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Raman, B., Bluemke, D. A., Lüscher, T. F., & Neubauer, S. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac031 · Cited by 650
Metadata
- Authors
- Pelliccia, A., Solberg, E. E., Papadakis, M., Adami, P. E., Biffi, A., Caselli, S., La Gerche, A., Niebauer, J., Pressler, A., Schmied, C. M., Serratosa, L., Halle, M., Van Buuren, F., Borjesson, M., Carrè, F., Panhuyzen-Goedkoop, N. M., Heidbuchel, H., Olivotto, I., Corrado, D., Sinagra, G., & Sharma, S.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-12-14
- Volume
- 40
- Issue
- 1
- Pages
- 19-33
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2903720062
- Cited by
- 442
- References
- 8
- FWCI
- 35.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). https://app.cochat.ai/papers/10.1093/eurheartj/ehy730
- The paper
- Pelliccia, A., Solberg, E. E., Papadakis, M., Adami, P. E., Biffi, A., Caselli, S., La Gerche, A., Niebauer, J., Pressler, A., Schmied, C. M., Serratosa, L., Halle, M., Van Buuren, F., Borjesson, M., Carrè, F., Panhuyzen-Goedkoop, N. M., Heidbuchel, H., Olivotto, I., Corrado, D., . . . Sharma, S. (2019). Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). European Heart Journal. https://doi.org/10.1093/eurheartj/ehy730
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.